Description

2,4(1H,3H)-Pyrimidinedione, 1-[2,5-Anhydro-4-C-[(Benzoyloxy)Methyl]-α-L-Lyxofuranosyl]- (9Ci) is a sophisticated nucleoside analog derivative, a key building block in advanced pharmaceutical research and development. Its complex structure, featuring a modified sugar moiety, makes it a critical intermediate for the synthesis of novel therapeutic agents. This high-purity compound is primarily utilized by research institutions and pharmaceutical companies focused on antiviral and anticancer drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel nucleoside-based antiviral and anticancer agents.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies to understand metabolic pathways and drug mechanisms of action.
• Medicinal Chemistry: Acts as a core scaffold for structure-activity relationship (SAR) studies to optimize drug potency and selectivity.
• Process Development: Employed in the scale-up and optimization of synthetic routes for active pharmaceutical ingredients (APIs).
• Reference Standard: Used as a high-purity analytical standard for quality control and method validation in pharmaceutical analysis.

Basic Information

Item	Detail
Product Name	2,4(1H,3H)-Pyrimidinedione, 1-[2,5-Anhydro-4-C-[(Benzoyloxy)Methyl]-α-L-Lyxofuranosyl]- (9Ci)
CAS No.	293751-31-2
Molecular Formula	C₁₇H₁₈N₂O₇
Molecular Weight	362.34 g/mol
Synonyms	1-(2,5-Anhydro-4-C-[(benzoyloxy)methyl]-α-L-lyxofuranosyl)-2,4(1H,3H)-pyrimidinedione; 1-(2,5-Anhydro-4-C-[(benzoyloxy)methyl]-α-L-lyxofuranosyl)uracil; Benzoylated Anhydrolyxofuranosyl Uracil; Nucleoside Analog Intermediate; Modified Uracil Derivative; 293751-31-2; 1-[2,5-Anhydro-4-C-[(Benzoyloxy)Methyl]-α-L-Lyxofuranosyl]uracil
EINECS	Contact for details

Quality Control

Every batch of this advanced intermediate is produced and tested under a strict quality management system. We provide comprehensive analytical data to ensure identity, purity, and consistency for your critical research and development projects. A detailed Certificate of Analysis (COA) is supplied with each shipment, typically including results from HPLC, NMR, and mass spectrometry. Our quality commitment supports compliance with cGMP guidelines for pharmaceutical starting materials.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound is moisture-sensitive (hygroscopic) and should be handled under an inert atmosphere when appropriate to ensure long-term stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.